InsidersTradesSigma
Track the 애드바이오텍 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 애드바이오텍 has recorded 6 public disclosures. Market capitalisation: €40.3bn. The latest transaction was filed on 18 June 2026 (Other). Among the most active insiders: 비케이파트너스투자조합1호. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
애드바이오텍 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical products.